C J Edwards1, R G Russell, T D Spector
1The Kennedy Institute of Rheumatology, Imperial College School of Medicine, London, UK.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Statins, or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, may increase bone mineral density and lower fracture risk. These findings suggest a role for cholesterol synthesis in bone health.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: